Barclays’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-424,121
| Closed | -$1.7M | – | 4104 |
|
2019
Q4 | $1.7M | Buy |
424,121
+366,103
| +631% | +$1.46M | ﹤0.01% | 1984 |
|
2019
Q3 | $284K | Sell |
58,018
-8,682
| -13% | -$42.5K | ﹤0.01% | 2906 |
|
2019
Q2 | $406K | Buy |
66,700
+28,590
| +75% | +$174K | ﹤0.01% | 2838 |
|
2019
Q1 | $221K | Buy |
38,110
+16,731
| +78% | +$97K | ﹤0.01% | 2992 |
|
2018
Q4 | $288K | Sell |
21,379
-37,754
| -64% | -$509K | ﹤0.01% | 2567 |
|
2018
Q3 | $1.15M | Sell |
59,133
-21,090
| -26% | -$409K | ﹤0.01% | 2177 |
|
2018
Q2 | $2.05M | Buy |
80,223
+3,243
| +4% | +$82.9K | ﹤0.01% | 1434 |
|
2018
Q1 | $1.55M | Sell |
76,980
-2,480
| -3% | -$50K | ﹤0.01% | 1515 |
|
2017
Q4 | $1.6M | Sell |
79,460
-41,728
| -34% | -$838K | ﹤0.01% | 1381 |
|
2017
Q3 | $2.51M | Sell |
121,188
-11,993
| -9% | -$248K | ﹤0.01% | 1109 |
|
2017
Q2 | $1.97M | Buy |
133,181
+81,525
| +158% | +$1.21M | ﹤0.01% | 1216 |
|
2017
Q1 | $823K | Sell |
51,656
-89,517
| -63% | -$1.43M | ﹤0.01% | 1672 |
|
2016
Q4 | $1.78M | Buy |
141,173
+94,104
| +200% | +$1.19M | ﹤0.01% | 1211 |
|
2016
Q3 | $1.32M | Buy |
47,069
+47,059
| +470,590% | +$1.32M | ﹤0.01% | 1270 |
|
2016
Q2 | $0 | Sell |
10
-90
| -90% | – | ﹤0.01% | 3986 |
|
2016
Q1 | $3K | Sell |
100
-172
| -63% | -$5.16K | ﹤0.01% | 3183 |
|
2015
Q4 | $9K | Sell |
272
-25
| -8% | -$827 | ﹤0.01% | 2839 |
|
2015
Q3 | $8K | Sell |
297
-3,804
| -93% | -$102K | ﹤0.01% | 3153 |
|
2015
Q2 | $180K | Buy |
4,101
+3,251
| +382% | +$143K | ﹤0.01% | 2113 |
|
2015
Q1 | $30K | Sell |
850
-90
| -10% | -$3.18K | ﹤0.01% | 2966 |
|
2014
Q4 | $26K | Buy |
+940
| New | +$26K | ﹤0.01% | 3326 |
|